NEW MEDICINAL FORM IN TREATMENT OF BRONCHIAL ASTHMA: FIXED COMBINATION OF FORMOTEROL AND BECLOMETASONE

<p><em>The article describes advantages of new combined drug Foster — formoterol (6 ?g) and beclometasone) (100 ?g) in treatment of patients with bronchial asthma. It was marked that the drug is based on original delivery technology «Modulite» allowing creation an aerosol with extra fine...

Full description

Bibliographic Details
Main Author: O.I. Simonova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2010-01-01
Series:Вопросы современной педиатрии
Online Access:http://vsp.spr-journal.ru:80/jour/article/view/905